Search Results 481-490 of 17254 for rheumatoid arthritis

  1. ENA test - Mayo Clinic

    Your health care professional may refer you to a doctor trained in autoimmune and arthritis conditions, called a rheumatologist. If the rheumatologist ...

  2. Neutropenia (low neutrophil count) Causes - Mayo Clinic

    Rheumatoid arthritis. Bone marrow disorders. Aplastic anemia · Myelodysplastic syndromes · Myelofibrosis. Additional causes. Conditions present at birth, such ...

  3. Rituximab (Intravenous Route) Precautions - Mayo Clinic

    The risk for getting this infection is higher if you have rheumatoid arthritis. Talk to your doctor about the benefits of receiving this medicine and the ...

  4. Fatigue Causes - Mayo Clinic

    Polymyalgia rheumatica; Pregnancy; Rheumatoid arthritis · Sleep apnea — a condition in which breathing stops and starts many times during sleep. Stress ...

  5. Kenneth J. Warrington, M.D. - Doctors and Medical Staff - Mayo Clinic

    Finn Minnesota Arthritis Foundation Professorship. ... Polyarteritis nodosa; Rheumatoid vasculitis ... MemberRheumatology Research Committee, Rheumatology Research, ...

  6. Unexplained weight loss - Mayo Clinic

    See also. 6 tips to manage rheumatoid arthritis symptoms · Acanthosis nigricans · Addison's disease · Adjuvant therapy for cancer · Adrenal fatigue: What causes ...

  7. Baricitinib (Oral Route) Proper Use - Mayo Clinic

    For rheumatoid arthritis: Adults—2 milligrams (mg) once a day. Children—Use and dose must be determined by your doctor. Missed Dose. If you miss a dose of ...

  8. Vagus nerve stimulation - Mayo Clinic

    Current research is looking at the potential benefits of the therapy for rheumatoid arthritis, inflammatory bowel disease, bipolar disorder, obesity and ...

  9. About the Team - Mayo Clinic Research

    ... rheumatoid arthritis (RA), osteoarthritis (OA) and cancer therapy. His work has garnered worldwide interest, as it introduced innovative approaches for RA ...

  10. Mayo Clinic Q and A: Medications in use and being tested for treatment of COVID-19

    The FDA has granted an emergency use authorization for baricitinib (Olumiant), a rheumatoid arthritis drug, to treat COVID-19 in some cases. Baricitinib is ...